Trials / Withdrawn
WithdrawnNCT01741376
Progesterone and Atomoxetine for Cocaine Cessation
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the role of progesterone (a hormone found in both men and women) on stopping cocaine use. The study will examine whether the medication, in combination with behavior therapy will decrease cocaine use, cigarette smoking, withdrawal symptoms, impulsivity and stress.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone | Progesterone 200 mg twice daily |
| DRUG | Placebo |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-12-04
- Last updated
- 2019-09-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01741376. Inclusion in this directory is not an endorsement.